Skip to content
value.today

IRulya Therapeutics Inc. vs Regenxbio Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Regenxbio Inc. is the larger company by market value: $513 M against $343 M for IRulya Therapeutics Inc., 1.5 times as much (market caps of Oct 30, 2026 for IRulya Therapeutics Inc. and Oct 6, 2026 for Regenxbio Inc.).
  • Both made a net loss: $84 M for IRulya Therapeutics Inc. and $194 M for Regenxbio Inc.
  • Regenxbio Inc. employs more people: 372 against 55 at IRulya Therapeutics Inc.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

02959881172020202120222023202420252026IRulya Therapeutics Inc. 23Regenxbio Inc. 35

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$0B$0B$0B$0B201720182019202020212022202320242025Regenxbio Inc. $0B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureIRulya Therapeutics Inc.
IRLA · #14,231 in the world
Regenxbio Inc.
RGNX · #12,428 in the world
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology
Founded——
Size
Market cap$343 M$513 M
Revenue—$170 M
Net income$-84 M▲ best$-194 M
Employees55372
Valuation
Price to sales—3.3×
Price to book—5.0×
Free cash flow yield-12.2%▲ best-24.6%
Profitability
Operating margin—-94.6%
Net margin—-113.8%
Return on equity—-107.0%
Growth
Revenue growth—104.5%
Revenue growth, 3 years a year—14.8%
Cash
Free cash flow margin—-74.1%
Altman Z-score zone—distress
Data as ofMarket cap Oct 2026; ratios FY2025Market cap Oct 2026; ratios FY2025

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, IRulya Therapeutics Inc. or Regenxbio Inc.?

Regenxbio Inc. is the larger company by market value: $513 M against $343 M for IRulya Therapeutics Inc., 1.5 times as much (market caps of Oct 30, 2026 for IRulya Therapeutics Inc. and Oct 6, 2026 for Regenxbio Inc.).

Which makes more money, IRulya Therapeutics Inc. or Regenxbio Inc.?

Both made a net loss: $84 M for IRulya Therapeutics Inc. and $194 M for Regenxbio Inc.

Which has more employees, IRulya Therapeutics Inc. or Regenxbio Inc.?

Regenxbio Inc. employs more people: 372 against 55 at IRulya Therapeutics Inc.

Sources#

Every figure on this page comes from these, with the date shown next to it.